Company Analysis

Cvs Health Corporation (CVS)

NYSE: CVS · Retail-Drug Stores and Proprietary Stores · Woonsocket, RI · filing with the SEC since 1994
Grade5.6
◀ Past 5.5● Present 6.0▶ Future 5.1
The companyfiscal 2025, as filed
Revenue$402.1B+7.8%
Net income$1.73B-62.3%
Earnings per share$1.39-62.0%
Operating cash flow$10.64B+16.8%
Cash$8.45B-1.5%
Debt$60.50B-0.0%
Shareholders’ equity$75.21B-0.5%
Shares, diluted1.27B+0.7%
Return on equity2.3%
The recordfrom its filings
Filings in 202662
Newest filingNov 6 · 4
Annual reportFeb 10, 2026
Quarterly reportNov 4, 2026
Next report due10-K by Mar 1
Insider sales, 12 months$324M
Insider buys, 12 months$2.0M
Patents granted253
Filer categoryLarge accelerated filer
Trailing twelve months to Sep 2026Revenue $420.6BNet income $11.05BCash from operations $18.71Bthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
16171819202122232425
As filed, in USD. Nothing here is a forecast.

The company now

CVS Health said on November 4, 2026 that it intends to separate into two independent, publicly traded companies 2. One would hold Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health, and the other about 9,000 CVS pharmacies, mail pharmacy, MinuteClinic and the Health100 technology business 2.

The company expects the separation to be completed in the first half of 2028, by a split intended to be tax-free to the company and its shareholders 2. It names final board approval, an effective Form 10 registration statement and tax confirmation among the conditions 2.

The same day it reported third-quarter 2026 revenue of $108.4 billion, up 5.4 percent from a year earlier 1. Adjusted earnings per share were $2.09 against $1.60 a year before, and the company raised its full-year adjusted outlook to at least $8.20 1.

The company credited the gain mainly to its insurance arm, where the medical benefit ratio, a measure of care costs against premiums, fell to 91.3 percent from 92.8 percent 1. Net income was $2.2 billion, against a $4.0 billion loss a year earlier that carried a $5.7 billion goodwill write-down 1.

The company says it keeps a cautious view for the rest of the year because of elevated cost trends and possible macro headwinds 1. It also called the sale of Omnicare's assets probable for the fourth quarter of 2026 3.

As of Nov 4, 2026. Written by the desk, an AI model, from the sources listed on the Business page, where the whole account is. Nothing here is advice.

News

Nov 6, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 4, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Nov 4, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Nov 4, 2026 · SEC EDGAR · Form 8-K
Results released
Open the filing on sec.gov
Aug 17, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Aug 5, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Aug 5, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton CVS · research, not advice